查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
微载体市场规模，占有率，趋势分析:各产品，各用途，各终端用户，各地区展望，竞争策略，至2030年的各市场区隔预测
市场调查报告书
商品编码
1089965

微载体市场规模，占有率，趋势分析:各产品，各用途，各终端用户，各地区展望，竞争策略，至2030年的各市场区隔预测

Microcarrier Market Size, Share & Trends Analysis By Product, By Application, By End User, Regional Outlook, Competitive Strategies and Segment Forecasts to 2030
出版日期: | 出版商: SPER Market Research Pvt. Ltd. | 英文 237 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

全球微载体的市场规模，预计今后以10.2％的年复合成长率扩大，至2030年达到40亿7,000万美元。由于气候变动和人口增加，病毒发生的风险高涨。因此，成为微载体市场成长的机会

本报告提供全球微载体市场相关调查，市场概要，以及各产品，各用途，各终端用户，各地区的趋势，及加入此市场的主要企业的简介等资讯。

目录

第1章 简介

第2章 调查手法

第3章 摘要整理

第4章 市场动态

  • 成长要素，阻碍因素，机会，课题的分析
    • 促进因素
    • 阻碍因素
    • 市场机会
    • 课题
  • COVID-19微载体市场的影响

第5章 市场变数及预测

  • SWOT分析
  • PESTEL分析
  • 波特的五力分析
  • 热图分析

第6章 全球微载体市场，各产品，2019年～2030年(100万美元)

  • 消耗品
    • 培养基
    • 试剂
    • 微载体
  • 设备
    • 生物反应器
    • 培养容器
    • 过滤及分离设备
    • 电池单元计数器
    • 其他

第7章 全球微载体市场，各用途，2019年～2030年(100万美元)

  • 生物医药品生产
    • 疫苗生产
    • 治疗性蛋白质生产
  • 细胞、基因治疗
  • 组织工程及再生医疗
  • 其他

第8章 全球微载体市场，各终端用户，2019年～2030年(100万美元)

  • 製药公司、生物科技企业
  • CRO，CMO
  • 学术研究机关
  • 电池单元银行

第9章 全球微载体市场，各地区，2019年～2030年(100万美元)

  • 北美
  • 欧洲
  • 亚太地区
  • 南美
  • 中东、非洲

第10章 企业简介

  • BD
  • CESCO Bioengineering
  • ChemoMetec
  • Corning
  • Danaher Corporation
  • Eppendorf AG
  • Fischer Scientific
  • HiMedia Laboratories
  • Merck
  • Sartorius AG
简介目录
Product Code: BIOT2231

Global microcarrier market is projected to be worth USD 4.07 billion by 2030.

According to SPER Market Research, the microcarrier market is estimated to reach USD 4.07 billion by 2030 with a CAGR of 10.2%. There is higher risk of virus outbreak due to climate change and increasing population. This creates opportunities for microcarrier market to grow.

Impact of COVID-19 on the Microcarrier Market

The outburst of COVID-19 infections at global level forced the governments to declare nation-wide lockdowns and norms for social distancing. The small and large players in pharmaceuticals focused on developing vaccines and other therapies against SARS-CoV-2 Research and development quickly escalated and were largely unaffected by the lockdowns and restrictions due to the support and funding. Demand for cell culture products also increased including microcarrier products. Cell culture is an important part of vaccine development which has increased the demand for microcarrier products.

Scope of the report:

  • Market size available for years: 2019-2030
  • Base year considered: 2021
  • Forecast period: 2022-2030
  • Segments covered: By Product, By Application, By End User
  • Geographies covered: North America, Europe, APAC, Latin America and the Middle East & Africa
  • Companies Covered: BD, CESCO Bioengineering, ChemoMetec, Corning, Danaher Corporation, Eppendorf AG, Fischer Scientific, HiMedia Laboratories, Merck, Sartorius AG

Driver: Increasing demand for cell-based vaccines

Rapidly increasing population, close proximity between animals and humans have created favorable conditions for virus outbreaks. This increases the demand for cell culture to develop cell-based vaccines. There is a higher risk of a pandemic in future creating urgent need for cell-based vaccines due to higher efficiency, large production capacity and shorter lead time. Clinical studies have also suggested cell-based vaccines as safe and effective for use in humans.

Restraints: High research and development cost

R&D in cell biology is an expensive process involving reagents and equipment of higher quality and precision in results. The high-quality standards issued by regulatory authorities increases the cost of the research. Thus, small players and academic institutes cannot afford to carry out this research which restraints the growth of this market in the forecast period.

Opportunity: Rising demand for monoclonal antibody

Monoclonal antibodies are increasing in demand for targeted delivery for cancer treatments and immune diseases. The monoclonal antibodies are administered at higher doses thus, production is also required equally high. This creates growth opportunities for microcarriers.

Microcarrier Market by Product:

Based on product, market has been segmented into Consumables (Media [Sera/Serum-based Media, Serum-free Media, Other Media], Reagents, Microcarriers [Collagen-coated Microcarriers, Cationic Microcarriers, Protein-coated Microcarriers, Untreated Microcarriers, Other Microcarriers]), Equipment (Bioreactors [Single-use Bioreactors, Stainless-steel Bioreactors], Culture Vessels, Filtration and Separation Equipment, Cell Counters, Other Equipment)

Microcarrier Market by Application:

Based on application, the market is segmented into Biopharmaceutical Production (Vaccine Production, Therapeutic Protein Production), Cell and Gene Therapy, Tissue Engineering and Regenerative Medicine, Other Applications

Microcarrier Market by End User:

Based on end user, the market is segmented into Pharmaceutical & Biotechnology Companies, Contract Research Organizations & Contract Manufacturing Organizations, Academic & Research Institutes, Cell Banks

Pharmaceutical & Biotechnological companies have the largest share of this market by end user due to changing regulatory scenarios of cell-based vaccines and rising awareness for cell-based vaccines for its benefits.

Microcarrier Market by Region:

North America owns the largest share of this market owing to increasing R&D activities, technological advancements, increasing investments and funding in cell-based research and presence of leading players of this market.

Table of Contents

1. Introduction

  • 1.1. Scope of the report
  • 1.2. Market segment analysis

2. Research Methodology

  • 2.1. Research data source
    • 2.1.1. Secondary data
    • 2.1.2. Primary data
    • 2.1.3. SPER's internal database
    • 2.1.4. Premium insight from KOL's
  • 2.2. Market size estimation
    • 2.2.1. Top-down and Bottom-up approach
  • 2.3. Data triangulation

3. Executive Summary

4. Market Dynamics

  • 4.1. Driver, Restraint, Opportunity and Challenges analysis
    • 4.1.1. Drivers
    • 4.1.2. Restraints
    • 4.1.3. Opportunities
    • 4.1.4. Challenges
  • 4.2. COVID-19 Impact of the Microcarrier Market

5. Market variables and outlook

  • 5.1. SWOT analysis
    • 5.1.1. Strengths
    • 5.1.2. Weaknesses
    • 5.1.3. Opportunities
    • 5.1.4. Threats
  • 5.2. PESTEL analysis
    • 5.2.1. Political landscape
    • 5.2.2. Economic landscape
    • 5.2.3. Social landscape
    • 5.2.4. Technological landscape
    • 5.2.5. Environmental landscape
    • 5.2.6. Legal landscape
  • 5.3. PORTER'S five forces analysis
    • 5.3.1. Bargaining power of suppliers
    • 5.3.2. Bargaining power of Buyers
    • 5.3.3. Threat of Substitute
    • 5.3.4. Threat of new entrant
    • 5.3.5. Competitive rivalry
  • 5.4. Heat map analysis

6. Global Microcarrier Market, By Product, 2019-2030 (USD Million)

  • 6.1. Consumables
    • 6.1.1. Media
      • 6.1.1.1. Sera/Serum-based Media
      • 6.1.1.2. Serum-free Media
      • 6.1.1.3. Other Media
    • 6.1.2. Reagents
    • 6.1.3. Microcarriers
      • 6.1.3.1. Collagen-coated Microcarriers
      • 6.1.3.2. Cationic Microcarriers
      • 6.1.3.3. Protein-coated Microcarriers
      • 6.1.3.4. Untreated Microcarriers
      • 6.1.3.5. Other Microcarriers
  • 6.2. Equipment
    • 6.2.1. Bioreactors
      • 6.2.1.1. Single-use Bioreactors
      • 6.2.1.2. Stainless-steel Bioreactors
    • 6.2.2. Culture Vessels
    • 6.2.3. Filtration and Separation Equipment
    • 6.2.4. Cell Counters
    • 6.2.5. Other Equipment

7. Global Microcarrier Market, By Application, 2019-2030 (USD Million)

  • 7.1. Biopharmaceutical Production
    • 7.1.1. Vaccine Production
    • 7.1.2. Therapeutic Protein Production
  • 7.2. Cell and Gene Therapy
  • 7.3. Tissue Engineering and Regenerative Medicine
  • 7.4. Other Applications

8. Global Microcarrier Market, By End User, 2019-2030 (USD Million)

  • 8.1. Pharmaceutical & Biotechnology Companies
  • 8.2. Contract Research Organizations & Contract Manufacturing Organizations
  • 8.3. Academic & Research Institutes
  • 8.4. Cell Banks

9. Global Microcarrier Market, By Region, 2019-2030 (USD Million)

  • 9.1. North America
    • 9.1.1. United States
    • 9.1.2. Canada
    • 9.1.3. Mexico
  • 9.2. Europe
    • 9.2.1. Germany
    • 9.2.2. United Kingdom
    • 9.2.3. France
    • 9.2.4. Italy
    • 9.2.5. Spain
    • 9.2.6. Rest of Europe
  • 9.3. Asia-Pacific
    • 9.3.1. China
    • 9.3.2. Japan
    • 9.3.3. India
    • 9.3.4. Australia
    • 9.3.5. South Korea
    • 9.3.6. Rest of Asia-Pacific
  • 9.4. South America
    • 9.4.1. Brazil
    • 9.4.2. Argentina
    • 9.4.3. Rest of South America
  • 9.5. Middle East & Africa
    • 9.5.1. Kingdom of Saudi Arabia
    • 9.5.2. United Arab Emirates
    • 9.5.3. Rest of Middle East & Africa

10. Company Profiles

  • 10.1. BD
    • 10.1.1. Company details
    • 10.1.2. Financial outlook
    • 10.1.3. Product summary
    • 10.1.4. Recent developments
  • 10.2. CESCO Bioengineering
    • 10.2.1. Company details
    • 10.2.2. Financial outlook
    • 10.2.3. Product summary
    • 10.2.4. Recent developments
  • 10.3. ChemoMetec
    • 10.3.1. Company details
    • 10.3.2. Financial outlook
    • 10.3.3. Product summary
    • 10.3.4. Recent developments
  • 10.4. Corning
    • 10.4.1. Company details
    • 10.4.2. Financial outlook
    • 10.4.3. Product summary
    • 10.4.4. Recent developments
  • 10.5. Danaher Corporation
    • 10.5.1. Company details
    • 10.5.2. Financial outlook
    • 10.5.3. Product summary
    • 10.5.4. Recent developments
  • 10.6. Eppendorf AG
    • 10.6.1. Company details
    • 10.6.2. Financial outlook
    • 10.6.3. Product summary
    • 10.6.4. Recent developments
  • 10.7. Fischer Scientific
    • 10.7.1. Company details
    • 10.7.2. Financial outlook
    • 10.7.3. Product summary
    • 10.7.4. Recent developments
  • 10.8. HiMedia Laboratories
    • 10.8.1. Company details
    • 10.8.2. Financial outlook
    • 10.8.3. Product summary
    • 10.8.4. Recent developments
  • 10.9. Merck
    • 10.9.1. Company details
    • 10.9.2. Financial outlook
    • 10.9.3. Product summary
    • 10.9.4. Recent developments
  • 10.10. Sartorius AG
    • 10.10.1. Company details
    • 10.10.2. Financial outlook
    • 10.10.3. Product summary
    • 10.10.4. Recent developments

9. Global Microcarrier Market, By Region, 2019-2030 (USD Million)

  • 9.1. North America
    • 9.1.1. United States
    • 9.1.2. Canada
    • 9.1.3. Mexico
  • 9.2. Europe
    • 9.2.1. Germany
    • 9.2.2. United Kingdom
    • 9.2.3. France
    • 9.2.4. Italy
    • 9.2.5. Spain
    • 9.2.6. Rest of Europe
  • 9.3. Asia-Pacific
    • 9.3.1. China
    • 9.3.2. Japan
    • 9.3.3. India
    • 9.3.4. Australia
    • 9.3.5. South Korea
    • 9.3.6. Rest of Asia-Pacific
  • 9.4. South America
    • 9.4.1. Brazil
    • 9.4.2. Argentina
    • 9.4.3. Rest of South America
  • 9.5. Middle East & Africa
    • 9.5.1. Kingdom of Saudi Arabia
    • 9.5.2. United Arab Emirates
    • 9.5.3. Rest of Middle East & Africa

10. Company Profiles

  • 10.1. BD
    • 10.1.1. Company details
    • 10.1.2. Financial outlook
    • 10.1.3. Product summary
    • 10.1.4. Recent developments
  • 10.2. CESCO Bioengineering
    • 10.2.1. Company details
    • 10.2.2. Financial outlook
    • 10.2.3. Product summary
    • 10.2.4. Recent developments
  • 10.3. ChemoMetec
    • 10.3.1. Company details
    • 10.3.2. Financial outlook
    • 10.3.3. Product summary
    • 10.3.4. Recent developments
  • 10.4. Corning
    • 10.4.1. Company details
    • 10.4.2. Financial outlook
    • 10.4.3. Product summary
    • 10.4.4. Recent developments
  • 10.5. Danaher Corporation
    • 10.5.1. Company details
    • 10.5.2. Financial outlook
    • 10.5.3. Product summary
    • 10.5.4. Recent developments
  • 10.6. Eppendorf AG
    • 10.6.1. Company details
    • 10.6.2. Financial outlook
    • 10.6.3. Product summary
    • 10.6.4. Recent developments
  • 10.7. Fischer Scientific
    • 10.7.1. Company details
    • 10.7.2. Financial outlook
    • 10.7.3. Product summary
    • 10.7.4. Recent developments
  • 10.8. HiMedia Laboratories
    • 10.8.1. Company details
    • 10.8.2. Financial outlook
    • 10.8.3. Product summary
    • 10.8.4. Recent developments
  • 10.9. Merck
    • 10.9.1. Company details
    • 10.9.2. Financial outlook
    • 10.9.3. Product summary
    • 10.9.4. Recent developments
  • 10.10. Sartorius AG
    • 10.10.1. Company details
    • 10.10.2. Financial outlook
    • 10.10.3. Product summary
    • 10.10.4. Recent developments